Kevin Brodbeck, Ph.D.

Kevin Brodbeck is the Chief Technical Officer at Deciphera Pharmaceuticals. As SVP of Technical and Development Operations, he oversees the Clinical Operations, CMC/Supply Chain and Program Management functions, and co-leads strategic portfolio governance for the company. In his tenure at Deciphera, he worked to expand Qinlock internationally, readied Romvimza for approval and launch in the US and EU and established strategic partnerships with commercial manufacturing and development organizations. Dr. Brodbeck joined Deciphera in 2023 and has over 25 years of experience in pharmaceutical development and drug delivery advancing products through early-stage and late-stage development. Prior to joining Deciphera, he served as Senior Vice President of Technical Operations for Nektar Therapeutics where he led development programs in anti-infective, pain, oncology, and immunotherapy ranging from early development to commercial. While at Nektar, he led the global CMC development and manufacturing organization consisting of product and process development, analytical sciences, internal and external manufacturing, quality assurance and control, and supply chain management. Before joining Nektar, Dr. Brodbeck held multiple product development leadership positions at ALZA / Johnson & Johnson and Powderject. Dr. Brodbeck received a B.S. in Chemical Engineering from the University of California, Berkeley and a Ph.D. in Chemical Engineering from University of Illinois, Urbana-Champaign.